174 related articles for article (PubMed ID: 19217595)
1. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma.
Purwosunu Y; Sekizawa A; Okazaki S; Farina A; Wibowo N; Nakamura M; Rizzo N; Saito H; Okai T
Am J Obstet Gynecol; 2009 Apr; 200(4):386.e1-7. PubMed ID: 19217595
[TBL] [Abstract][Full Text] [Related]
2. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
3. PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia.
Shimizu H; Sekizawa A; Purwosunu Y; Nakamura M; Farina A; Rizzo N; Okai T
Prenat Diagn; 2009 Dec; 29(13):1231-6. PubMed ID: 19813218
[TBL] [Abstract][Full Text] [Related]
4. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
6. Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study.
Basbug M; Demir I; Serin IS; Ozcelik B; Saraymen R; Narin F; Tayyar M
J Perinat Med; 2003; 31(6):469-74. PubMed ID: 14711102
[TBL] [Abstract][Full Text] [Related]
7. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks.
Farina A; Zucchini C; Sekizawa A; Purwosunu Y; de Sanctis P; Santarsiero G; Rizzo N; Morano D; Okai T
Am J Obstet Gynecol; 2010 Dec; 203(6):575.e1-7. PubMed ID: 20934680
[TBL] [Abstract][Full Text] [Related]
8. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
[TBL] [Abstract][Full Text] [Related]
9. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
10. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia.
Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Okazaki S; Nakamura M; Samura O; Fujito N; Okai T
Prenat Diagn; 2007 Aug; 27(8):772-7. PubMed ID: 17554801
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.
Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Koide K; Okazaki S; Nakamura M; Okai T
Am J Obstet Gynecol; 2008 Jan; 198(1):124.e1-7. PubMed ID: 18166325
[TBL] [Abstract][Full Text] [Related]
12. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
[TBL] [Abstract][Full Text] [Related]
13. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening.
Farina A; Sekizawa A; Iwasaki M; Matsuoka R; Ichizuka K; Okai T
Prenat Diagn; 2004 Sep; 24(9):722-6. PubMed ID: 15386446
[TBL] [Abstract][Full Text] [Related]
14. Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia.
Zeng X; Sun Y; Yang HX; Li D; Li YX; Liao QP; Wang YL
Am J Obstet Gynecol; 2009 Dec; 201(6):618.e1-7. PubMed ID: 19766985
[TBL] [Abstract][Full Text] [Related]
15. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.
Chavarría ME; Lara-González L; García-Paleta Y; Vital-Reyes VS; Reyes A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):157-64. PubMed ID: 17706337
[TBL] [Abstract][Full Text] [Related]
16. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women.
Okazaki S; Sekizawa A; Purwosunu Y; Farina A; Wibowo N; Okai T
Obstet Gynecol; 2007 Nov; 110(5):1130-6. PubMed ID: 17978129
[TBL] [Abstract][Full Text] [Related]
17. A discriminant function for preeclampsia: case-control study of minor hemoglobins, red cell enzymes, and clinical laboratory values.
Braun KP; Gant NF; Olson CM; Parisi V; Forrest KA; Peterson CM
Am J Perinatol; 1997 May; 14(5):297-302. PubMed ID: 9259948
[TBL] [Abstract][Full Text] [Related]
18. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia.
Moretti M; Phillips M; Abouzeid A; Cataneo RN; Greenberg J
Am J Obstet Gynecol; 2004 May; 190(5):1184-90. PubMed ID: 15167816
[TBL] [Abstract][Full Text] [Related]
19. Pressor response to cycle ergometry in the midtrimester of pregnancy: can it predict preeclampsia?
Watson WJ; Katz VL; Caprice PA; Jones L; Welter SM
Am J Perinatol; 1995 Jul; 12(4):265-7. PubMed ID: 7575832
[TBL] [Abstract][Full Text] [Related]
20. Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia.
Thilaganathan B; Ralph E; Papageorghiou AT; Melchiorre K; Sheldon J
Reprod Sci; 2009 Aug; 16(8):788-93. PubMed ID: 19436062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
